DocMorris AG (DOCM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, DocMorris AG (DOCM) has a cash flow conversion efficiency ratio of -0.116x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-55.66 Million ≈ $-70.36 Million USD) by net assets (CHF480.35 Million ≈ $607.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See DocMorris AG (DOCM) defensive interval to measure how many days the company can operate on defensive assets alone.
DocMorris AG - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how DocMorris AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.
DocMorris AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DocMorris AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rocky Brands Inc
NASDAQ:RCKY
|
0.007x |
|
Sygnia Ltd
JSE:SYG
|
0.363x |
|
Forcecon Technology Co Ltd
TWO:3483
|
0.030x |
|
SinoDaan Co Ltd
SHE:300635
|
0.015x |
|
Guangzhou Improve Med Instrument
SHE:300030
|
0.104x |
|
Bank Multiarta Sentosa PT
JK:MASB
|
0.033x |
|
Ive Group Ltd
AU:IGL
|
0.158x |
|
Shenzhen Maxonic Auto Control
SHE:300112
|
0.016x |
Annual Cash Flow Conversion Efficiency for DocMorris AG (2010–2024)
The table below shows the annual cash flow conversion efficiency of DocMorris AG from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see DocMorris AG (DOCM) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CHF340.11 Million ≈ $430.00 Million |
CHF-26.60 Million ≈ $-33.63 Million |
-0.078x | +61.48% |
| 2023-12-31 | CHF430.53 Million ≈ $544.31 Million |
CHF-87.42 Million ≈ $-110.52 Million |
-0.203x | +26.79% |
| 2022-12-31 | CHF350.78 Million ≈ $443.48 Million |
CHF-97.29 Million ≈ $-123.00 Million |
-0.277x | -2.96% |
| 2021-12-31 | CHF484.92 Million ≈ $613.07 Million |
CHF-130.63 Million ≈ $-165.15 Million |
-0.269x | -112.18% |
| 2020-12-31 | CHF531.74 Million ≈ $672.26 Million |
CHF-67.51 Million ≈ $-85.35 Million |
-0.127x | +37.64% |
| 2019-12-31 | CHF405.54 Million ≈ $512.71 Million |
CHF-82.57 Million ≈ $-104.39 Million |
-0.204x | -171.83% |
| 2018-12-31 | CHF443.61 Million ≈ $560.84 Million |
CHF-33.23 Million ≈ $-42.01 Million |
-0.075x | +0.85% |
| 2017-12-31 | CHF294.22 Million ≈ $371.98 Million |
CHF-22.23 Million ≈ $-28.10 Million |
-0.076x | +43.30% |
| 2016-12-31 | CHF103.81 Million ≈ $131.24 Million |
CHF-13.83 Million ≈ $-17.48 Million |
-0.133x | -151.38% |
| 2015-12-31 | CHF72.78 Million ≈ $92.01 Million |
CHF18.87 Million ≈ $23.86 Million |
0.259x | +178.59% |
| 2014-12-31 | CHF77.35 Million ≈ $97.79 Million |
CHF7.20 Million ≈ $9.10 Million |
0.093x | +240.84% |
| 2013-12-31 | CHF73.38 Million ≈ $92.77 Million |
CHF2.00 Million ≈ $2.53 Million |
0.027x | -88.74% |
| 2012-12-31 | CHF85.79 Million ≈ $108.46 Million |
CHF20.81 Million ≈ $26.31 Million |
0.243x | +607.10% |
| 2011-12-31 | CHF81.80 Million ≈ $103.42 Million |
CHF2.81 Million ≈ $3.55 Million |
0.034x | -80.54% |
| 2010-12-31 | CHF79.19 Million ≈ $100.12 Million |
CHF13.96 Million ≈ $17.65 Million |
0.176x | -- |
About DocMorris AG
DocMorris AG operates as an online pharmacy, telemedicine, and healthcare company in Switzerland and internationally. It offers prescription and over-the-counter medicines, and consumer health products, as well as beauty and personal care products, nutritional supplements, painkillers, and first aid products. The company also provides professional health care services to doctors, pharmacies, insu… Read more